跳至主要内容
临床试验/NL-OMON50918
NL-OMON50918招募中不适用

Fluorescence guided surgery for intra-operative detection of meningioma using Bevacizumab-IRDye800CW - Fluorescence guided surgery of meningioma using Bevacizumab-800CW (LUMINA)

niversitair Medisch Centrum Groningen0 个研究点目标入组 19 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
19

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Age >= 18 years;
  • - Patients with convexity or sphenoid wing meningioma determined by
  • preoperative imaging, e.g. MRI and/or CT;
  • - Scheduled to undergo elective resection at the UMCG as part of the standard
  • preoperative work- up;
  • - Mentally competent person who is able and willing to comply with study
  • procedures;
  • - Signed written informed consent.

排除标准

  • - Has been injected with another Investigational Medicinal Product (IMP) within
  • the past month;
  • - Concomitant malignancies, except for adequately treated basocellular
  • carcinoma of the skin or in situ carcinoma of the cervix uteri. Subjects with
  • prior malignancies must be disease-free for at least five years;
  • - Previous allergic reaction to Bevacizumab;
  • - Medical or psychiatric conditions that compromise the patient*s ability to
  • give informed consent;
  • - Pregnant or lactating women. During standard of care, pregnancy is a
  • contraindication for elective (neuro)surgical procedures. Therefore, the
  • possibility of pregnancy will be discussed with women of childbearing potential
  • (defined as premenopausal women with intact reproductive organs and women less
  • than two years after menopause).

研究者

相似试验

Fluorescence guided surgery for intra-operative... | 临床试验